PROM1 and neoplasm: De novo expression of CD133 in human embryonic kidney 293 (HEK293) cells conferred tumour-initiating capacity to these otherwise CD133-negative cells, strongly suggesting that CD133 actively contributes to the TIC phenotype of malignant cells.